Form 8-K - Current report:
SEC Accession No. 0001628280-16-019270
Filing Date
2016-08-26
Accepted
2016-08-26 16:59:53
Documents
3
Period of Report
2016-08-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ETHYOL DISTRIBUTION a8k-ethyoldistribution.htm 8-K 20648
2 EXHIBIT 99.1 - PRESS RELEASE ethyolpressrelease-distrib.htm EX-99.1 6790
3 cumberlanda02.jpg GRAPHIC 96793
  Complete submission text file 0001628280-16-019270.txt   161830
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 161855372
SIC: 2834 Pharmaceutical Preparations